Exposure | Comparator | Unadjusted relative hazard (95Â % CI) | Adjusteda relative hazard (95Â % CI) |
---|---|---|---|
TNFi monotherapy | MTX | 1.12 (0.70–1.78) | 1.19 (0.72–1.94) |
TNFi + MTX combination | MTX | 1.21 (0.69–2.10) | 1.23 (0.69–2.17) |
 Hospitalized infection during baseline | No infection during baseline |  | 3.28 (1.44–7.48) |
 Nonprimary hospitalized or outpatient infection during baseline | No infection during baseline |  | 1.72 (1.12–2.63) |
 High-dose oral GC (≥10 mg/day) | No oral GC use during baseline |  | 2.03 (1.21–3.39) |
 Low-dose oral GC (<10 mg/day) | No oral GC use during baseline |  | 0.86 (0.50–1.46) |